|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IN THIS ISSUE |
|
The new cells were discovered in mice whose own bone marrow had been eliminated by irradiation and replaced with donor bone marrow. The irradiation eliminates all immune cells except for epidermal LCs. Six weeks after bone marrow transplant, Bursch et al. found that epidermal LCs were primarily from the host, as expected. But they also found donor-derived DCs that expressed langerin in the dermis and lymph nodes. These new DCs were also spotted circulating in the blood by Ginhoux et al. and in the lung and liver by Bursch et al. Poulin et al. showed that the dermal langerin+ DCs expressed surface markers distinct from those expressed by classic LCs.
The dermal DCs repopulated the skin more rapidly than LCs after toxin-induced DC elimination, according to Bursch et al. This finding may explain prior DC depletion studies, which showed that allergic skin reactions—thought to require T cell activation by epidermal LCs—occurred before the LCs could repopulate the skin.
The precise role of the new langerin+ DCs is not yet clear. They have been seen clustering around hair follicles in the upper dermis, which may give them access to antigens that do not penetrate more deeply. Their rapid renewal and trafficking to lymph nodes might also be important in protecting the dermis against infection when the epidermis is injured. What these cells are doing in the lung and the liver, however, is a bigger mystery. 
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Related Articles
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
